Herriliberg, Switzerland

Wilhelm Krek

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Herrliberg, CH (2016)
  • Herriliberg, CH (2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Wilhelm Krek: Innovator in Cancer Biomarker Discovery

Introduction

Wilhelm Krek is a prominent inventor based in Herriliberg, Switzerland. He has made significant contributions to the field of cancer diagnostics, particularly in the discovery of biomarkers for prostate cancer. With a total of 2 patents, Krek's work focuses on innovative methods that enhance the accuracy of cancer detection and treatment.

Latest Patents

Krek's latest patents include a method for biomarker and drug-target discovery for prostate cancer diagnosis and treatment. This invention relates to biomarker assays based on protein and peptide biomarkers that exhibit distinct behaviors between healthy and cancerous sample proteomes. The methods involve mass spectrometric measurements and antibody-based assays, such as Enzyme-Linked Immunosorbent Assay (ELISA), to determine the presence of these biomarkers in serum, plasma, or blood samples.

Another significant patent by Krek outlines a comprehensive method for identifying cancer diagnostic and therapeutic biomarkers. This process includes several steps: identifying potential candidate biomarkers based on protein concentrations in tissue and blood samples, verifying these candidates through quantitative mass spectrometry, and validating them using statistical methods to establish reliable signatures for cancer detection.

Career Highlights

Throughout his career, Wilhelm Krek has worked with esteemed institutions such as ETH Zurich and Kantonsspital St. Gallen. His research has significantly advanced the understanding of cancer biomarkers and their applications in clinical settings.

Collaborations

Krek has collaborated with notable colleagues, including Igor Cima and Rudolf Aebersold, contributing to the advancement of cancer research and diagnostics.

Conclusion

Wilhelm Krek's innovative work in cancer biomarker discovery has the potential to revolutionize prostate cancer diagnosis and treatment. His contributions to the field underscore the importance of research in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…